Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1996-11-12
pubmed:abstractText
To determine the efficacy of isolated limb perfusion (ILP) with tumor necrosis factor-alpha (TNF) in combination with interferon-gamma (IFN) and melphalan as induction therapy to render tumors resectable and avoid amputation in patients with nonresectable extremity soft tissue sarcomas (STS).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2653-65
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:8874324-Adolescent, pubmed-meshheading:8874324-Adult, pubmed-meshheading:8874324-Aged, pubmed-meshheading:8874324-Aged, 80 and over, pubmed-meshheading:8874324-Antineoplastic Agents, Alkylating, pubmed-meshheading:8874324-Chemotherapy, Cancer, Regional Perfusion, pubmed-meshheading:8874324-Extremities, pubmed-meshheading:8874324-Female, pubmed-meshheading:8874324-Hemodynamics, pubmed-meshheading:8874324-Humans, pubmed-meshheading:8874324-Interferon-gamma, pubmed-meshheading:8874324-Male, pubmed-meshheading:8874324-Melphalan, pubmed-meshheading:8874324-Middle Aged, pubmed-meshheading:8874324-Remission Induction, pubmed-meshheading:8874324-Salvage Therapy, pubmed-meshheading:8874324-Sarcoma, pubmed-meshheading:8874324-Treatment Outcome, pubmed-meshheading:8874324-Tumor Necrosis Factor-alpha
pubmed:year
1996
pubmed:articleTitle
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial.
pubmed:affiliation
Department of Surgical Oncology, University Hospital Rotterdam-Daniel den Hoed Cancer Center, The Netherlands. eggermont@chih.azr.nl
pubmed:publicationType
Journal Article, Multicenter Study